Table of Contents Author Guidelines Submit a Manuscript
Sarcoma
Volume 2016, Article ID 5043640, 11 pages
http://dx.doi.org/10.1155/2016/5043640
Research Article

Ewing’s Sarcoma as a Second Malignancy in Long-Term Survivors of Childhood Hematologic Malignancies

1Department of Neurology, University Hospital Zurich, Frauenklinikstrasse 26, 8091 Zurich, Switzerland
2Department of Medical Oncology, University Hospital Zurich, Rämistrasse 100, 8091 Zurich, Switzerland
3Department of Pediatric Oncology, University Children’s Hospital, Zurich, Steinwiesstrasse 75, 8032 Zurich, Switzerland
4Institute of Surgical Pathology, University Hospital Zurich, Schmelzbergstrasse 12, 8091 Zurich, Switzerland
5Department of Neuropathology, University Hospital Zurich, Schmelzbergstrasse 12, 8091 Zurich, Switzerland

Received 3 April 2016; Accepted 19 June 2016

Academic Editor: Natia Esiashvili

Copyright © 2016 Fabian Wolpert et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. P. C. Nathan, B. Hayes-Lattin, J. J. Sisler, and M. M. Hudson, “Critical issues in transition and survivorship for adolescents and young adults with cancers,” Cancer, vol. 117, no. 10, pp. 2335–2341, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. A. Kishtagari, M. Tavakkoli, and J. H. Park, “Survivorship in adolescents and young adults,” Acta Haematologica, vol. 132, no. 3-4, pp. 383–390, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. D. K. Choi, I. Helenowski, and N. Hijiya, “Secondary malignancies in pediatric cancer survivors: perspectives and review of the literature,” International Journal of Cancer, vol. 135, no. 8, pp. 1764–1773, 2014. View at Publisher · View at Google Scholar · View at Scopus
  4. K. Dunleavy, M. Roschewski, and W. H. Wilson, “Precision treatment of distinct molecular subtypes of diffuse large B-cell lymphoma: ascribing treatment based on the molecular phenotype,” Clinical Cancer Research, vol. 20, no. 20, pp. 5182–5193, 2014. View at Publisher · View at Google Scholar · View at Scopus
  5. J. D. Tward, M. M. M. Wendland, D. C. Shrieve, A. Szabo, and D. K. Gaffney, “The risk of secondary malignancies over 30 years after the treatment of non-Hodgkin lymphoma,” Cancer, vol. 107, no. 1, pp. 108–115, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. N. Esiashvili, M. Goodman, and R. B. Marcus Jr., “Changes in incidence and survival of Ewing sarcoma patients over the past 3 decades: surveillance epidemiology and end results data,” Journal of Pediatric Hematology/Oncology, vol. 30, no. 6, pp. 425–430, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. M. A. Applebaum, J. Worch, K. K. Matthay et al., “Clinical features and outcomes in patients with extraskeletal Ewing sarcoma,” Cancer, vol. 117, no. 13, pp. 3027–3032, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. N. J. Balamuth and R. B. Womer, “Ewing's sarcoma,” The Lancet Oncology, vol. 11, no. 2, pp. 184–192, 2010. View at Publisher · View at Google Scholar · View at Scopus
  9. E.-Y. K. Choi, J. M. Gardner, D. R. Lucas, J. B. McHugh, and R. M. Patel, “Ewing sarcoma,” Seminars in Diagnostic Pathology, vol. 31, no. 1, pp. 39–47, 2014. View at Publisher · View at Google Scholar · View at Scopus
  10. G. M. Ibrahim, A. Fallah, M. Shahideh, U. Tabori, and J. T. Rutka, “Primary Ewing's sarcoma affecting the central nervous system: a review and proposed prognostic considerations,” Journal of Clinical Neuroscience, vol. 19, no. 2, pp. 203–209, 2012. View at Publisher · View at Google Scholar · View at Scopus
  11. E. de Alava, L. S. Lessnik, and P. H. Sorensen, “Ewing sarcoma,” in WHO Classification of Tumours of Soft Tissue and Bone, C. D. M. Fletcher, J. A. Bridge, P. C. W. Hogendoorn, and F. Mertens, Eds., pp. 305–309, IARC, Lyon, France, 2013. View at Google Scholar
  12. K. N. Ganjoo and S. Patel, “The treatment outcome for adult patients with Ewing's sarcoma,” Current Oncology Reports, vol. 15, no. 4, pp. 372–377, 2013. View at Publisher · View at Google Scholar · View at Scopus
  13. T. G. P. Grünewald, V. Bernard, P. Gilardi-Hebenstreit et al., “Chimeric EWSR1-FLI1 regulates the Ewing sarcoma susceptibility gene EGR2 via a GGAA microsatellite,” Nature Genetics, vol. 47, no. 9, pp. 1073–1078, 2015. View at Publisher · View at Google Scholar · View at Scopus
  14. N. Hiramoto, Y. Kobayashi, J. Nomoto et al., “Ewing sarcoma arising after treatment of diffuse large B-cell lymphoma,” Japanese Journal of Clinical Oncology, vol. 43, no. 4, pp. 417–421, 2013. View at Publisher · View at Google Scholar · View at Scopus
  15. N. Vanhapiha, S. Knuutila, K. Vettenranta, and O. Lohi, “Burkitt lymphoma and Ewing sarcoma in a child with Williams syndrome,” Pediatric Blood and Cancer, vol. 61, no. 10, pp. 1877–1879, 2014. View at Publisher · View at Google Scholar · View at Scopus
  16. B. Bode-Lesniewska, J. Hodler, A. von Hochstetter, L. Guillou, U. Exner, and R. Caduff, “Late solitary bone metastasis of a primary pulmonary synovial sarcoma with SYT-SSX1 translocation type: case report with a long follow-up,” Virchows Archiv, vol. 446, no. 3, pp. 310–315, 2005. View at Publisher · View at Google Scholar · View at Scopus
  17. U. Yamaguchi, T. Hasegawa, Y. Morimoto et al., “A practical approach to the clinical diagnosis of Ewing's sarcoma/primitive neuroectodermal tumour and other small round cell tumours sharing EWS rearrangement using new fluorescence in situ hybridisation probes for EWSR1 on formalin fixed, paraffin wax embedded tissue,” Journal of Clinical Pathology, vol. 58, no. 10, pp. 1051–1056, 2005. View at Publisher · View at Google Scholar · View at Scopus
  18. B. Bode, S. Frigerio, S. Behnke et al., “Mutations in the tyrosine kinase domain of the EGFR gene are rare in synovial sarcoma,” Modern Pathology, vol. 19, no. 4, pp. 541–547, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. D. Modritz, R. Ladenstein, U. Pötschger et al., “Treatment for soft tissue sarcoma in childhood and adolescence. Austrian results within the CWS 96 study,” Wiener Klinische Wochenschrift, vol. 117, no. 5-6, pp. 196–209, 2005. View at Publisher · View at Google Scholar · View at Scopus
  20. J. Zhong, N. Chen, X. Chen et al., “Peripheral primitive neuroectodermal tumor of the kidney in a 51-year-old female following breast cancer: a case report and review of the literature,” Oncology Letters, vol. 9, no. 1, pp. 108–112, 2015. View at Publisher · View at Google Scholar · View at Scopus
  21. M. Cole, S. Parajuli, D. Laske et al., “Peripheral primitive neuroectodermal tumor of the dura in a 51-year-old woman following intensive treatment for breast cancer,” American Journal of Case Reports, vol. 15, pp. 294–299, 2014. View at Publisher · View at Google Scholar · View at Scopus
  22. K. J. Helton, B. D. Fletcher, L. E. Kun, J. J. Jenkins III, and C. B. Pratt, “Bone tumors other than osteosarcoma after retinoblastoma,” Cancer, vol. 71, no. 9, pp. 2847–2853, 1993. View at Publisher · View at Google Scholar · View at Scopus
  23. J. U. Cope, M. Tsokos, and R. W. Miller, “Ewing sarcoma and sinonasal neuroectodermal tumors as second malignant tumors after retinoblastoma and other neoplasms,” Medical and Pediatric Oncology, vol. 36, no. 2, pp. 290–294, 2001. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Tanik, K. Zengin, S. Albayrak, R. Eryilmaz, D. Yilmaz, and N. Pirinçci, “Cutaneous Ewing's sarcoma secondary to chemotherapy given for testis tumor: case report,” International Journal of Surgery Case Reports, vol. 5, no. 12, pp. 972–974, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. A. Applebaum, R. Goldsby, J. Neuhaus, and S. G. DuBois, “Clinical features and outcomes in patients with secondary Ewing sarcoma,” Pediatric Blood and Cancer, vol. 60, no. 4, pp. 611–615, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Tilly, C. Bastard, B. Chevallier, E. Halkin, and M. Monconduit, “Chromosomal abnormalities in secondary Ewing's sarcoma,” The Lancet, vol. 324, no. 8406, p. 812, 1984. View at Publisher · View at Google Scholar · View at Scopus
  27. A. T. Meadows, G. J. D'Angio, V. Mike et al., “Patterns of second malignant neoplasms in children,” Cancer, vol. 40, supplement 4, pp. 1903–1911, 1977. View at Publisher · View at Google Scholar · View at Scopus
  28. A. Zoubek, I. Simonitsch, E. R. Panzer-Grümayer et al., “Ewing tumor after treatment of Ki-1+ anaplastic large cell lymphoma Therapy-associated secondary neoplasm or unrelated coincidence?” Cancer Genetics and Cytogenetics, vol. 83, no. 1, pp. 5–11, 1995. View at Publisher · View at Google Scholar · View at Scopus
  29. F. Antillon, S. C. Kaste, J. J. Jenkins et al., “Primitive neuroectodermal tumor of bone as a second malignant neoplasm in a child previously treated for acute lymphoblastic leukemia,” Journal of Pediatric Hematology/Oncology, vol. 19, no. 5, pp. 473–476, 1997. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Aparicio, A. Segura, J. Montalar, A. Verdeguer, V. Castel, and A. B. Sanchez-Heras, “Letter to the editor: ‘secondary cancers after ewing sarcoma and ewing sarcoma as second malignant neoplasm’,” Medical and Pediatric Oncology, vol. 30, no. 4, pp. 259–260, 1998. View at Google Scholar · View at Scopus
  31. G. Bisogno, G. Sotti, Y. Nowicki et al., “Soft tissue sarcoma as a second malignant neoplasm in the pediatric age group,” Cancer, vol. 100, no. 8, pp. 1758–1765, 2004. View at Publisher · View at Google Scholar · View at Scopus
  32. G. E. Kim, B. Beach, J. M. Gastier-Foster et al., “Ewing sarcoma as a second malignant neoplasm after acute lymphoblastic leukemia,” Pediatric Blood & Cancer, vol. 45, no. 1, pp. 57–59, 2005. View at Google Scholar
  33. S. L. Spunt, C. Rodriguez-Galindo, C. E. Fuller et al., “Ewing sarcoma-family tumors that arise after treatment of primary childhood cancer,” Cancer, vol. 107, no. 1, pp. 201–206, 2006. View at Publisher · View at Google Scholar · View at Scopus
  34. A. P. Anselmo, C. Cartoni, A. Pacchiarotti et al., “Peripheral neuroectodermal tumor of the chest (Askin tumor) as secondary neoplasm after Hodgkin's disease: a case report,” Annals of Hematology, vol. 68, no. 6, pp. 311–313, 1994. View at Publisher · View at Google Scholar · View at Scopus
  35. R. Delgado-Chavez, P. Sobrevilla-Calvo, L. Green-Schneewiss, E. Reynoso-Gomez, and L. Quintanilla-Martinez, “Peripheral neuroectodermal tumor of the chest wall in a patient treated for Hodgkin's disease,” Leukemia and Lymphoma, vol. 17, no. 5-6, pp. 509–513, 1995. View at Publisher · View at Google Scholar · View at Scopus
  36. C. R. Suarez, S. J. Bertolone, A. B. Raj, and S. Coventry, “Second malignant neoplasms in childhood acute lymphoblastic leukemia: primitive neuroectodermal tumor of the chest wall with germline p53 mutation as a second malignant neoplasm,” American Journal of Hematology, vol. 76, no. 1, pp. 52–56, 2004. View at Publisher · View at Google Scholar · View at Scopus
  37. A. Khadwal, G. Biswas, B. Arora, P. A. Kurkure, C. Deshmukh, and V. Shetty, “Primitive neuroectodermal tumor (PNET) as second malignancy after treatment of Hodgkin's disease,” Indian Journal of Pediatrics, vol. 73, no. 5, pp. 437–438, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. S. Osone, H. Hosoi, K. Tanaka et al., “A case of a Ewing sarcoma family tumor in the urinary bladder after treatment for acute lymphoblastic leukemia,” Journal of Pediatric Hematology/Oncology, vol. 29, no. 12, pp. 841–844, 2007. View at Publisher · View at Google Scholar · View at Scopus
  39. M. Renard, S. Suciu, Y. Bertrand et al., “Second neoplasm in children treated in EORTC 58881 trial for acute lymphoblastic malignancies: low incidence of CNS tumours,” Pediatric Blood and Cancer, vol. 57, no. 1, pp. 119–125, 2011. View at Publisher · View at Google Scholar · View at Scopus
  40. S. H. Lim, J. Y. Lee, J. Y. Lee et al., “Unusual presentation of Ewing sarcoma in the adrenal gland: a secondary malignancy from a survivor of Burkitt lymphoma,” Japanese Journal of Clinical Oncology, vol. 43, no. 6, pp. 676–680, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. T. O. Henderson, J. Whitton, M. Stovall et al., “Secondary sarcomas in childhood cancer survivors: a report from the childhood cancer survivor study,” Journal of the National Cancer Institute, vol. 99, no. 4, pp. 300–308, 2007. View at Publisher · View at Google Scholar · View at Scopus
  42. J. Manner, B. Radlwimmer, P. Hohenberger et al., “MYC high level gene amplification is a distinctive feature of angiosarcomas after irradiation or chronic lymphedema,” The American Journal of Pathology, vol. 176, no. 1, pp. 34–39, 2010. View at Publisher · View at Google Scholar · View at Scopus
  43. J.-F. Egger, J.-M. Coindre, J. Benhattar, P. Coucke, and L. Guillou, “Radiation-associated synovial sarcoma: clinicopathologic and molecular analysis of two cases,” Modern Pathology, vol. 15, no. 9, pp. 998–1004, 2002. View at Publisher · View at Google Scholar · View at Scopus
  44. M. Joannides and D. Grimwade, “Molecular biology of therapy-related leukaemias,” Clinical and Translational Oncology, vol. 12, no. 1, pp. 8–14, 2010. View at Publisher · View at Google Scholar · View at Scopus
  45. J. L. Nitiss, “Targeting DNA topoisomerase II in cancer chemotherapy,” Nature Reviews Cancer, vol. 9, no. 5, pp. 338–350, 2009. View at Publisher · View at Google Scholar · View at Scopus
  46. M. Pendleton, R. H. Lindsey, C. A. Felix, D. Grimwade, and N. Osheroff, “Topoisomerase II and leukemia,” Annals of the New York Academy of Sciences, vol. 1310, no. 1, pp. 98–110, 2014. View at Publisher · View at Google Scholar · View at Scopus
  47. C. N. Duncan, N. S. Majhail, R. Brazauskas et al., “Long-term survival and late effects among one-year survivors of second allogeneic hematopoietic cell transplantation for relapsed acute leukemia and myelodysplastic syndromes,” Biology of Blood and Marrow Transplantation, vol. 21, no. 1, pp. 151–158, 2015. View at Publisher · View at Google Scholar · View at Scopus
  48. W. Leung, G. Neale, F. Behm et al., “Deficient innate immunity, thymopoiesis, and gene expression response to radiation in survivors of childhood acute lymphoblastic leukemia,” Cancer Epidemiology, vol. 34, no. 3, pp. 303–308, 2010. View at Publisher · View at Google Scholar · View at Scopus
  49. T. Moriyama, M. V. Relling, and J. J. Yang, “Inherited genetic variation in childhood acute lymphoblastic leukemia,” Blood, vol. 125, no. 26, pp. 3988–3995, 2015. View at Publisher · View at Google Scholar · View at Scopus
  50. J. Zhang, M. F. Walsh, G. Wu et al., “Germline mutations in predisposition genes in pediatric cancer,” The New England Journal of Medicine, vol. 373, no. 24, pp. 2336–2346, 2015. View at Publisher · View at Google Scholar · View at Scopus
  51. M. C. Chandhanayingyong, N. M. Bernthal, P. Ungarreevittaya, S. D. Nelson, S. P. Chawla, and A. S. Singh, “Ewing sarcoma in a patient with Cowden syndrome,” Journal of the National Comprehensive Cancer Network, vol. 13, no. 11, pp. 1310–1314, 2015. View at Google Scholar · View at Scopus
  52. P. A. Marrero Barrera and P. V. Marrero Ortiz, “Ewing sarcoma superimposed on a previous osteochondroma in multiple osteochondromatosis,” Orthopedics, vol. 37, no. 4, pp. e403–e406, 2014. View at Publisher · View at Google Scholar · View at Scopus
  53. I. Sultan, R. Rihani, R. Hazin, and C. Rodriguez-Galindo, “Second malignancies in patients with Ewing Sarcoma Family of Tumors: a population-based study,” Acta Oncologica, vol. 49, no. 2, pp. 237–244, 2010. View at Publisher · View at Google Scholar · View at Scopus